This caught my eye from the April 8, 2021 online JAMA:

https://jamanetwork.com/journals/jama/fullarticle/2778599?guestAccessKey=882928d9-e2c8-4906-b5e9-2d0f51b49f93&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=etoc&utm_term=052521

" A novel variant of SARS-CoV-2, B.1.1.7, originally discovered in the UK, is rapidly overtaking wild-type SARS-CoV-2 globally,1 due to a substantial transmission advantage. This variant is estimated to be 40% to 80% more transmissible2 and 35% more lethal3 than the wild-type virus."

I'm not a doctor so perhaps there's one reading the board who can correct me if I'm wrong, but the term wild-type virus is interesting. Do they mean the garden variety virus that gained in function with the help of Fauci's NIH financial backing and the one that initially got loose from the lab? Or are they assuming it was an animal virus that jumped to humans in the wild? Has the virus the vaccines were coded to work on now morphed into a more deadly U.K. variant? And is it more deadly because the vaccine has made people more susceptible to variants because it directs their immune system to fight the original virus and less so the variants like this that it would normally be able to handle had a person not taken the vaccination?

It seems to me that this will be the next reason to get a booster shot. And why everyone will need to go back that already got a vax in order to now fight this variant. What then happens when compromised immune systems are further compromised with the booster so the body is completely focused on 2 strains of virus...the original Wuhan flu and now this U.K. variant and something else pops up elsewhere that kills off even more people who had the original vaccine and the booster? Is this how the depopulation of planet earth happens?

These were the references from above quote:

1. Kupferschmidt K. Danish scientists see tough times ahead as variant rises.  Science. 2021;371(6529):549-550. doi:10.1126/science.371.6529.549PubMedGoogle ScholarCrossref

2. Volz E, Mishra S, Chand M, et al. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data.  MedRxiv. Preprint posted on January 24, 2021. Accessed January 28, 2021. doi:10.1101/2020.12.30.20249034Google Scholar

3. Davies NG, Abbott S, Barnard RC, et al; CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.  Science. 2021;372(6538):eabg3055. doi:10.1126/science.abg3055PubMedGoogle Scholar